V. B. Markeev, V. P. Vinogradov, S. V. Tishkov, E. V. Blynskaya, K. V. Alekseev, V. L. Dorofeev
{"title":"聚乙烯醇-己内酰胺、聚乙烯醇-乙酸乙烯-聚乙二醇接枝的非晶态固体分散体对n -丁基- n -甲基-1-苯基吡咯[1,2-a]吡嗪-3-羧酰胺结晶度和溶解动力学的影响","authors":"V. B. Markeev, V. P. Vinogradov, S. V. Tishkov, E. V. Blynskaya, K. V. Alekseev, V. L. Dorofeev","doi":"10.3103/S0027131425700245","DOIUrl":null,"url":null,"abstract":"<p>Poor water solubility, which negatively influences the bioavailability of oral medications, is typical for the vast majority of molecules (up to 70%) developed as active pharmaceutical ingredients (API). Amorphous solid dispersions of <i>N</i>-butyl-<i>N</i>-methyl-1-phenylpyrrolo[1,2-a]pyrazine-3-carboxamide (GML-3) with a Soluplus® polymer are developed in this study. The inclusion of GML-3, which is almost insoluble in water and has antidepressant and anxiolytic action, in the solid dispersions makes it possible to convert it from a crystalline to an amorphous state. The amorphous state of the solid dispersions is confirmed by X-ray phase analysis and differential scanning calorimetry. The interaction between the polymer and GML-3 inside the dispersions is revealed. It is possible to achieve 98.4% solubility of GML-3 in water via the preparation of GML-3 solid dispersions with Soluplus®, which solves the problem of solubility of this API.</p>","PeriodicalId":709,"journal":{"name":"Moscow University Chemistry Bulletin","volume":"80 4","pages":"233 - 238"},"PeriodicalIF":0.5000,"publicationDate":"2025-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Influence of Amorphous Solid Dispersions with a Grafted Copolymer of Polyvinylcaprolactam, Polyvinyl Acetate, and Polyethylene Glycol on the Crystallinity and Dissolution Kinetics of N-Butyl-N-methyl-1-phenylpyrrolo[1,2-a]pyrazine-3-carboxamide\",\"authors\":\"V. B. Markeev, V. P. Vinogradov, S. V. Tishkov, E. V. Blynskaya, K. V. Alekseev, V. L. Dorofeev\",\"doi\":\"10.3103/S0027131425700245\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Poor water solubility, which negatively influences the bioavailability of oral medications, is typical for the vast majority of molecules (up to 70%) developed as active pharmaceutical ingredients (API). Amorphous solid dispersions of <i>N</i>-butyl-<i>N</i>-methyl-1-phenylpyrrolo[1,2-a]pyrazine-3-carboxamide (GML-3) with a Soluplus® polymer are developed in this study. The inclusion of GML-3, which is almost insoluble in water and has antidepressant and anxiolytic action, in the solid dispersions makes it possible to convert it from a crystalline to an amorphous state. The amorphous state of the solid dispersions is confirmed by X-ray phase analysis and differential scanning calorimetry. The interaction between the polymer and GML-3 inside the dispersions is revealed. It is possible to achieve 98.4% solubility of GML-3 in water via the preparation of GML-3 solid dispersions with Soluplus®, which solves the problem of solubility of this API.</p>\",\"PeriodicalId\":709,\"journal\":{\"name\":\"Moscow University Chemistry Bulletin\",\"volume\":\"80 4\",\"pages\":\"233 - 238\"},\"PeriodicalIF\":0.5000,\"publicationDate\":\"2025-08-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Moscow University Chemistry Bulletin\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://link.springer.com/article/10.3103/S0027131425700245\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"CHEMISTRY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Moscow University Chemistry Bulletin","FirstCategoryId":"1085","ListUrlMain":"https://link.springer.com/article/10.3103/S0027131425700245","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0
摘要
水溶性差会对口服药物的生物利用度产生负面影响,这对于作为活性药物成分(API)开发的绝大多数分子(高达70%)来说是典型的。本研究开发了n -丁基- n -甲基-1-苯基吡咯[1,2-a]吡嗪-3-羧酰胺(GML-3)与Soluplus®聚合物的无定形固体分散体。GML-3几乎不溶于水,具有抗抑郁和抗焦虑作用,在固体分散体中包含GML-3,使其有可能从结晶状态转化为无定形状态。用x射线相分析和差示扫描量热法证实了固体分散体的非晶态。揭示了聚合物与分散体内部GML-3的相互作用。通过使用Soluplus®制备GML-3固体分散体,可以使GML-3在水中的溶解度达到98.4%,解决了该原料药的溶解度问题。
The Influence of Amorphous Solid Dispersions with a Grafted Copolymer of Polyvinylcaprolactam, Polyvinyl Acetate, and Polyethylene Glycol on the Crystallinity and Dissolution Kinetics of N-Butyl-N-methyl-1-phenylpyrrolo[1,2-a]pyrazine-3-carboxamide
Poor water solubility, which negatively influences the bioavailability of oral medications, is typical for the vast majority of molecules (up to 70%) developed as active pharmaceutical ingredients (API). Amorphous solid dispersions of N-butyl-N-methyl-1-phenylpyrrolo[1,2-a]pyrazine-3-carboxamide (GML-3) with a Soluplus® polymer are developed in this study. The inclusion of GML-3, which is almost insoluble in water and has antidepressant and anxiolytic action, in the solid dispersions makes it possible to convert it from a crystalline to an amorphous state. The amorphous state of the solid dispersions is confirmed by X-ray phase analysis and differential scanning calorimetry. The interaction between the polymer and GML-3 inside the dispersions is revealed. It is possible to achieve 98.4% solubility of GML-3 in water via the preparation of GML-3 solid dispersions with Soluplus®, which solves the problem of solubility of this API.
期刊介绍:
Moscow University Chemistry Bulletin is a journal that publishes review articles, original research articles, and short communications on various areas of basic and applied research in chemistry, including medical chemistry and pharmacology.